Inscripta is a Biotechnology company based in Boulder, CO. It has raised $499M in total funding. Latest round: Series E.
Inscripta funding overview
Inscripta is a Biotechnology company based in Boulder, CO. Inscripta has raised $499M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in December 2022. The round record for Inscripta runs through 2022; nothing later has been disclosed.
Inscripta at a glance
Total raised
$499M
Latest round
Series E
Latest round date
December 2022
Industry
Biotechnology
Headquarters
Boulder, CO
Frequently asked about Inscripta funding
How much has Inscripta raised?
Inscripta has raised $499M in total disclosed funding across the rounds on record.
Who has invested in Inscripta?
No investors are named on the public record for Inscripta yet.
What was the latest Inscripta funding round?
The most recent disclosed round is a Series E, announced in December 2022.
Where is Inscripta based?
Inscripta is based in Boulder, CO.
What sector does Inscripta operate in?
Inscripta is tracked under Biotechnology from Boulder, CO, with $499M in disclosed funding.
When did Inscripta last raise?
The last disclosed Inscripta round closed in December 2022 at Series E.
Totals shown for Inscripta aggregate every disclosed round on file. To see how that compares, browse the Biotechnology companies in Boulder and the investors behind them below.
